Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
PubMed
16809314
PubMed Central
PMC1489063
DOI
10.1128/jvi.02694-05
PII: 80/14/7089
Knihovny.cz E-zdroje
- MeSH
- bezbuněčný systém MeSH
- genom virový fyziologie MeSH
- genové produkty gag genetika metabolismus MeSH
- HIV-1 izolace a purifikace fyziologie ultrastruktura MeSH
- kapsida metabolismus ultrastruktura MeSH
- konformace proteinů MeSH
- lidé MeSH
- Masonův-Pfizerův opičí virus izolace a purifikace fyziologie MeSH
- mutace MeSH
- oligonukleotidy genetika metabolismus MeSH
- RNA ribozomální genetika metabolismus MeSH
- RNA virová genetika metabolismus ultrastruktura MeSH
- sestavení viru fyziologie MeSH
- terciární struktura proteinů genetika MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- genové produkty gag MeSH
- oligonukleotidy MeSH
- RNA ribozomální MeSH
- RNA virová MeSH
In contrast to other retroviruses, Mason-Pfizer monkey virus (M-PMV) assembles immature capsids in the cytoplasm. We have compared the ability of minimal assembly-competent domains from M-PMV and human immunodeficiency virus type 1 (HIV-1) to assemble in vitro into virus-like particles in the presence and absence of nucleic acids. A fusion protein comprised of the capsid and nucleocapsid domains of Gag (CANC) and its N-terminally modified mutant (DeltaProCANC) were used to mimic the assembly of the viral core and immature particles, respectively. In contrast to HIV-1, where CANC assembled efficiently into cylindrical structures, the same domains of M-PMV were assembly incompetent. The addition of RNA or oligonucleotides did not complement this defect. In contrast, the M-PMV DeltaProCANC molecule was able to assemble into spherical particles, while that of HIV-1 formed both spheres and cylinders. For M-PMV, the addition of purified RNA increased the efficiency with which DeltaProCANC formed spherical particles both in terms of the overall amount and the numbers of completed spheres. The amount of RNA incorporated was determined, and for both rRNA and MS2-RNA, quantities similar to that of genomic RNA were encapsidated. Oligonucleotides also stimulated assembly; however, they were incorporated into DeltaProCANC spherical particles in trace amounts that could not serve as a stoichiometric structural component for assembly. Thus, oligonucleotides may, through a transient interaction, induce conformational changes that facilitate assembly, while longer RNAs appear to facilitate the complete assembly of spherical particles.
Zobrazit více v PubMed
Accola, M. A., B. Strack, and G. Gottlinger. 2000. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74:5395-5402. PubMed PMC
Barklis, E., J. McDermott, S. Wilkens, S. Fuller, and D. Thompson. 1998. Organization of HIV-1 capsid proteins on a lipid monolayer. J. Biol. Chem. 273:7177-7180. PubMed
Berkowitz, R., J. Fisher, and S. P. Goff. 1996. RNA packaging. Curr. Top. Microbiol. Immunol. 214:177-218. PubMed
Berthtet-Colominas, C., S. Monaco, A. Novelli, G. Sibai, F. Mallet, and S. Cusack. 1999. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with monoclonal antibody Fab. EMBO J. 18:1124-1136. PubMed PMC
Birkett, A. J., B. Yelamos, I. Rodriguez-Crespo, F. Gavilanes, and D. L. Peterson. 1997. Cloning, expression, purification and characterization of the major core protein (p26) from equine infectious anemia virus. Biochim. Biophys. Acta 1339:62-72. PubMed
Borsetti, A., A. Ohagen, and H. G. Gottlinger. 1998. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J. Virol. 72:9313-9317. PubMed PMC
Bowles, N. E., P. Damay, and P.-F. Spahr. 1993. Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein. J. Virol. 67:623-631. PubMed PMC
Briggs, J. A. G., T. Wilk, R. Welker, H. G. Kräusslich, and S. D. Fuller. 2003. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 22:1707-1715. PubMed PMC
Briggs, J. A. G., M. N. Simon, I. Gross, H. G. Kräusslich, S. D. Fuller, V. M. Vogt, and M. C. Johnson. 2004. The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol. 11:672-675. PubMed
Campbell, S., and V. M. Vogt. 1995. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69:6487-6497. PubMed PMC
Campbell, S., and V. M. Vogt. 1997. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles. J. Virol. 71:4425-4435. PubMed PMC
Campbell, S., and A. Rein. 1999. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J. Virol. 73:2270-2279. PubMed PMC
Campos-Olivas, R., J. L. Newman, and M. F. Summers. 2000. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J. Mol. Biol. 296:633-649. PubMed
Cimarelli, A., and J. L. Darlix. 2002. Assembling the human immunodeficiency virus type 1. Cell. Mol. Life Sci. 59:1166-1184. PubMed PMC
Cornilescu, C. C., F. Bouamr, X. Yao, C. Carter, and N. Tjandra. 2001. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein. J. Mol. Biol. 306:783-797. PubMed
Dannull, J., A. Surovoy, G. Jung, and K. Moelling. 1994. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13:1525-1533. PubMed PMC
Darlix, J. L., M. Lapadat-Tapolsky, H. de Rocquigny, and B. P. Roques. 1995. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254:523-537. PubMed
De Rocquigny, H., C. Gabus, A. Vincent, M. C. Fournie-Zaluski, B. Roques, and J. L. Darlix. 1992. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl. Acad. Sci. USA 89:6472-6476. PubMed PMC
Dorfman, T., J. Luban, S. P. Goff, W. A. Haseltine, and H. G. Gottlinger. 1993. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67:6159-6169. PubMed PMC
Dorfman, T., A. Bukovsky, A. Ohagen, S. Hoglund, and H. G. Gottlinger. 1994. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:8180-8187. PubMed PMC
Dupraz, P., S. Oertle, C. Méric, P. Damay, and P.-F. Spahr. 1990. Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein. J. Virol. 64:4978-4987. PubMed PMC
Ehrlich, L. S., B. E. Agresta, and C. A. Carter. 1992. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:4874-4883. PubMed PMC
Ehrlich, L. S., T. Liu, S. Scarlata, B. Chu, and C. A. Carter. 2001. HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes. Biophys. J. 81:586-594. PubMed PMC
Feng, Y. X., T. Li, S. Campbell, and A. Rein. 2002. Reversible binding of recombinant human immunodeficiency virus type 1 Gag protein to nucleic acids in virus-like particle assembly in vitro. J. Virol. 76:11757-11762. PubMed PMC
Fuller, S. D., T. Wilk, B. D. Gowen, H. G. Kräusslich, and V. M. Vogt. 1997. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr. Biol. 7:729-738. PubMed
Gamble, T. L., F. F. Vajdos, S. Yoo, D. K. Worthylake, M. Houseweart, W. I. Sundquist, and C. P. Hill. 1996. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285-1294. PubMed
Gamble, T. L., S. Yoo, F. F. Vajdos, U. K. von Schwedler, D. K. Worthylake, H. Wang, J. P. McCutcheon, W. I. Sundquist, and C. P. Hill. 1997. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278:849-853. PubMed
Ganser, B. K., S. Li, V. Y. Klishko, J. T. Finch, and W. I. Sundquist. 1999. Assembly and analysis of conical models for the HIV-1 core. Science 283:80-83. PubMed
Ganser-Pornillos, B. K., U. K. von Schwedler, K. M. Stray, C. Aiken, and W. I. Sundquist. 2004. Assembly properties of the human immunodeficiency virus type 1 CA protein. J. Virol. 78:2545-2552. PubMed PMC
Gao, Y., K. Kaluarachchi, and D. P. Giedroc. 1998. Solution structure and backbone dynamics of Mason-Pfizer monkey virus, MPMV, nucleocapsid protein. Prot. Sci. 7:2265-2280. PubMed PMC
Gitti, R. K., B. M. Lee, J. Walker, M. F. Summers, S. Yoo, and W. I. Sundquist. 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231-235. PubMed
Gorelick, R. J., S. M. Nigida, L. O. Arthur, L. E. Henderson, and A. Rein. 1988. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a “zinc finger-like” protein sequence. Proc. Natl. Acad. Sci. USA 85:8420-8424. PubMed PMC
Gorelick, R. J., S. M. J. Nigida, J. W. J. Bess, L. O. Arthur, L. E. Henderson, and A. Rein. 1990. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64:3207-3211. PubMed PMC
Gorelick, R. J., S. M. Nigida, L. O. Arthur, L. E. Henderson, and A. Rein. 1991. Role of nucleocapsid cysteine arrays in retroviral assembly and replication: possible mechanisms in RNA encapsidation. In A. Kumar (ed.), Advances in molecular biology and targeted treatment for AIDS. Plenum Press, New York, N.Y.
Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036. PubMed PMC
Gross, I., H. Hohenberg, and H. G. Kräusslich. 1997. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 249:592-600. PubMed
Gross, I., H. Hohenberg, C. Huckhagel, and H. G. Kräusslich. 1998. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72:4798-4810. PubMed PMC
Gross, I., H. Hohenberg, T. Wilk, K. Wiegers, M. Grättinger, B. Mūller, S. Fuller, and H. G. Kräusslich. 2000. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 19:103-113. PubMed PMC
Ivanov, D., J. R. Stone, J. L. Maki, T. Collins, and G. Wagner. 2005. Mammalian SCAN domain dimer is a domain-swapped homolog of the HIV capsid C-terminal domain. Mol. Cell 17:137-143. PubMed
Johnson, M. C., H. M. Scobie, Y. M. Ma, and V. M. Vogt. 2002. Nucleic acid-independent retrovirus assembly can be driven by dimerization. J. Virol. 76:11177-11185. PubMed PMC
Joshi, S. M., and V. M. Vogt. 2000. Role of the Rous sarcoma virus p10 domain in shape determination of Gag virus-like particles assembled in vitro and within Escherichia coli. J. Virol. 74:10260-10268. PubMed PMC
Karpel, R. L., L. E. Henderson, and S. Oroszlan. 1987. Interactions of retroviral structural proteins with single-stranded nucleic acids. J. Biol. Chem. 262:4961-4967. PubMed
Khorasanizadeh, S., R. Campos-Olivas, and M. F. Summers. 1999. Solution structure of the capsid protein from the human T-cell leukemia virus type-1. J. Mol. Biol. 291:491-505. PubMed
Kingston, R., E. Z. Eisenmesser, T. Fitzon-Ostendorp, G. W. Schatz, V. M. Vogt, C. B. Post, and M. G. Rossmann. 2000. Structure and self-association of the Rous sarcoma virus capsid protein. Structure 8:617-628. PubMed
Kingston, R. L., and V. M. Vogt. 2005. Domain swapping and retroviral assembly. Mol. Cell 17:166-167. PubMed
Klikova, M., S. S. Rhee, E. Hunter, and T. Ruml. 1995. Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria. J. Virol. 69:1093-1098. PubMed PMC
Lanman, J., J. Sexton, M. Sakalian, and P. E. Prevelige, Jr. 2002. Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro. J. Virol. 76:6900-6908. PubMed PMC
Lanman, J., T. T. Lam, M. R. Emmett, A. G. Marshall, M. Sakalian, and P. E. Prevelige, Jr. 2004. Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 11:676-677. PubMed
Levin, J. G., P. M. Grimley, J. M. Ramseur, and I. K. Berezesky. 1974. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 14:152-161. PubMed PMC
Li, S., C. P. Hill, W. I. Sundquist, and J. T. Finch. 2000. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409-413. PubMed
Linial, M., E. Medeiros, and W. S. Hayward. 1978. An avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell 15:1371-1381. PubMed
Linial, M. L., and A. D. Miller. 1990. Retroviral RNA packaging: sequence requirements and implications. Curr. Top. Microbiol. 157:125-152. PubMed
Ma, Y. M., and V. M. Vogt. 2002. Rous sarcoma virus Gag protein-oligonucleotide interaction suggests a critical role for protein dimer formation in assembly. J. Virol. 76:5452-5462. PubMed PMC
Ma, Y. M., and V. M. Vogt. 2004. Nucleic acid binding-induced Gag dimerization in the assembly of Rous sarcoma virus particles in vitro. J. Virol. 78:52-60. PubMed PMC
Méric, C., and P.-F. Spahr. 1986. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 60:450-459. PubMed PMC
Méric, C., and S. P. Goff. 1989. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J. Virol. 63:1558-1568. PubMed PMC
Momany, C., L. C. Kovari, A. J. Prongay, W. Keller, R. K. Gitti, B. M. Lee, A. E. Gorbalenya, L. Tong, J. McClure, L. S. Ehrlich, M. F. Summers, C. Carter, and M. G. Rossmann. 1996. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 3:763-770. PubMed
Morikawa, Y., T. Goto, and K. Sano. 1999. In vitro assembly of human immunodeficiency virus type 1 Gag protein. J. Biol. Chem. 274:27997-28002. PubMed
Morikawa, Y., T. Goto, and F. Momose. 2004. Human immunodeficiency virus type 1 gag assembly through assembly intermediates. J. Biol. Chem. 279:31964-31972. PubMed
Muriaux, D., J. Mirro, D. Harvin, and A. Rein. 2001. RNA is structural element in retrovirus particles. Proc. Natl. Acad. Sci. USA 98:5246-5251. PubMed PMC
Nandhagopal, N., A. A. Simpson, M. C. Johnson, A. B. Francisco, G. W. Schatz, M. G. Rossman, and V. M. Vogt. 2004. Dimeric Rous sarcoma virus capsid protein structure relevant to immature Gag assembly. J. Mol. Biol. 335:275-282. PubMed
Nermut, V. N., P. Bron, D. Thomas, M. Rumlova, T. Ruml, and E. Hunter. 2002. Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli. J. Virol. 76:4321-4330. PubMed PMC
Parker, S. D., J. S. Wall, and E. Hunter. 2001. Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy. J. Virol. 75:9543-9548. PubMed PMC
Poon, D. T., J. Wu, and A. Aldovini. 1996. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 70:6607-6616. PubMed PMC
Reicin, A. S., S. Paik, R. D. Berkowitz, J. Luban, I. Lowy, and S. P. Goff. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:642-650. PubMed PMC
Rein, A. 1994. Retroviral RNA packaging: a review. Arch. Virol. Suppl. 9:513-522. PubMed
Rein, A., D. P. Harvin, J. Mirro, S. M. Ernst, and R. J. Gorelick. 1994. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. J. Virol. 68:6124-6129. PubMed PMC
Roldan, A., R. S. Russell, B. Marchand, M. Götte, C. Liang, and M. A. Wainberg. 2004. In vitro identification and characterization of an early complex linking HIV-1 genomic RNA recognition and Pr55Gag multimerization. J. Biol. Chem. 279:39886-39894. PubMed
Rumlova-Klikova, M., E. Hunter, M. V. Nermut, I. Pichova, and T. Ruml. 2000. Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape. J. Virol. 74:8452-8459. PubMed PMC
Rumlova, M., T. Ruml, J. Pohl, and I. Pichova. 2003. Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection. Virology 310:310-318. PubMed
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Schmalzbauer, E., B. Strack, J. Dannull, S. Guehmann, and K. Moelling. 1996. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro. J. Virol. 70:771-777. PubMed PMC
Urbaneja, M. A., B. P. Kane, D. G. Johnson, R. J. Gorelick, L. E. Henderson, and J. Casas-Finet. 1999. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function. J. Mol. Biol. 287:59-75. PubMed
Urbaneja, M. A., C. F. McGrath, B. P. Kane, L. E. Henderson, and J. Casas-Finet. 2000. Nucleic acid binding properties of the simian immunodeficiency virus nucleocapsid protein NCp8. J. Biol. Chem. 275:10394-10404. PubMed
Vogt, M. V., and M. Simon. 1999. Mass determination of Rous sarcoma virus virions by scanning transmission electron microscopy. J. Virol. 73:7050-7055. PubMed PMC
von Schwedler, U. K., T. L. Stemmler, V. Y. Klishko, S. Li, K. H. Albertine, D. R. Davis, and W. I. Sundquist. 1998. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1555-1568. PubMed PMC
von Schwedler, U. K., K. M. Stray, J. E. Garrus, and W. I. Sundquist. 2003. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77:5439-5450. PubMed PMC
Wang, S. W., and A. Aldovini. 2002. RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes. J. Virol. 76:11853-11865. PubMed PMC
Wang, S. W., K. Noonan, and A. Aldovini. 2004. Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses. J. Virol. 78:716-723. PubMed PMC
You, J. C., and C. S. McHenry. 1993. HIV nucleocapsid protein: expression in Escherichia coli, purification, and characterization. J. Biol. Chem. 268:16519-16527. PubMed
Yu, F., S. M. Joshi, Y. M. Ma, R. L. Kingston, M. N. Simon, and V. M. Vogt. 2001. Characterization of Rous sarcoma virus Gag particles assembled in vitro. J. Virol. 75:2753-2764. PubMed PMC
Zhang, Y., H. Qian, Z. Love, and E. Barklis. 1998. Analysis of the assembly function of the human immunodeficiency virus type 1 Gag protein nucleocapsid domain. J. Virol. 72:1782-1789. PubMed PMC
Zlotnick, A. 2003. Are weak protein-protein interactions the general rule in capsid assembly? Virology 315:269-274. PubMed
PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles
A simple, high-throughput stabilization assay to test HIV-1 uncoating inhibitors
In vitro methods for testing antiviral drugs
Nucleic Acid Binding by Mason-Pfizer Monkey Virus CA Promotes Virus Assembly and Genome Packaging
Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles
In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV
Multimerization of the p12 domain is necessary for Mason-Pfizer monkey virus Gag assembly in vitro